ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000

NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines

November 26, 1993

R. Lee Clark to Retire; Texas Starts Search for Successor

September 9, 1977

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997